Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-044397
Filing Date
2017-08-21
Accepted
2017-08-21 16:13:51
Documents
47
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v472068_10q.htm 10-Q 452494
2 EXHIBIT 31.1 v472068_ex31-1.htm EX-31.1 10008
3 EXHIBIT 32.1 v472068_ex32-1.htm EX-32.1 6378
  Complete submission text file 0001144204-17-044397.txt   3187577

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgrx-20170630.xml EX-101.INS 779036
5 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20170630.xsd EX-101.SCH 30727
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20170630_cal.xml EX-101.CAL 19951
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20170630_def.xml EX-101.DEF 171196
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20170630_lab.xml EX-101.LAB 193794
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20170630_pre.xml EX-101.PRE 195308
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 171043247
SIC: 2834 Pharmaceutical Preparations